Takeda Pharmaceutical Co (SSE:4502) FCF Margin % : 6.24% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Takeda Pharmaceutical Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Takeda Pharmaceutical Co's Free Cash Flow for the three months ended in Dec. 2023 was 円69,327 Mil. Takeda Pharmaceutical Co's Revenue for the three months ended in Dec. 2023 was 円1,111,186 Mil. Therefore, Takeda Pharmaceutical Co's FCF Margin % for the quarter that ended in Dec. 2023 was 6.24%.

As of today, Takeda Pharmaceutical Co's current FCF Yield % is -2.01%.

The historical rank and industry rank for Takeda Pharmaceutical Co's FCF Margin % or its related term are showing as below:

SSE:4502' s FCF Margin % Range Over the Past 10 Years
Min: -3.28 Med: 8.95 Max: 26.26
Current: -3.1

During the past 13 years, the highest FCF Margin % of Takeda Pharmaceutical Co was 26.26%. The lowest was -3.28%. And the median was 8.95%.

SSE:4502's FCF Margin % is ranked worse than
55.85% of 1026 companies
in the Drug Manufacturers industry
Industry Median: -0.68 vs SSE:4502: -3.10

Takeda Pharmaceutical Co FCF Margin % Historical Data

The historical data trend for Takeda Pharmaceutical Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co FCF Margin % Chart

Takeda Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

FCF Margin %

Get a 7-Day Free Trial

9.27

13.73

24.22

26.26

8.53

Takeda Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															29.88	-15.73	-16.70	12.35	6.24

Competitive Comparison of Takeda Pharmaceutical Co's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Takeda Pharmaceutical Co's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's FCF Margin % falls into.

Takeda Pharmaceutical Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Takeda Pharmaceutical Co's FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	343467	/	4027478
	=	8.53 %

Takeda Pharmaceutical Co's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	69327	/	1111186
	=	6.24 %

Takeda Pharmaceutical Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co (SSE:4502) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (SSE:4502) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

TAK:USA TKPHF:USA TAK:Mexico 4502:Japan TKD:Germany TAKP34:Brazil

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co (SSE:4502) Headlines

No Headlines